19 Hrs
Source:
Financial Times
Samsung Biologics acquires Swiss peptide firm
PolyPeptide's takeover highlights how South Korean companies are increasingly expanding internationally through acquisitions. This trend reflects broader efforts by South Korean firms to strengthen their global presence.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)